Tumor-Immune Spatial Interaction Analysis Service
In the era of precision oncology, knowing if immune cells are present in a tumor is no longer enough. To truly understand therapeutic response, we need to know where they are, who they are talking to, and how their spatial organization dictates the fate of the disease.
Our Tumor-Immune Spatial Interaction Analysis service provides a high-resolution, multi-dimensional map of the tumor microenvironment (TME). By combining cutting-edge multiplex imaging with advanced computational geography, we help researchers and clinicians decode the complex "social network" of cancer cells and the immune system.
Submit Your Request Now
×
- What is
- Workflow
- Deliverables
- Applications
- Why choose
- FAQs
- Sample preparation
What is Tumor-Immune Spatial Interaction Analysis?
Traditional bulk sequencing and flow cytometry provide a "smoothie" view of a tumor—they tell you the ingredients but lose the structure. Spatial interaction analysis, however, preserves the "fruit salad" view.
It is a specialized bioinformatics and imaging approach that quantifies the physical proximity and functional relationships between malignant cells and various immune populations (such as CD8+ T cells, Macrophages, and Tregs). By measuring metrics like cell-to-cell distance, neighborhood density, and boundary infiltration, we can identify whether a tumor is "Hot" (infiltrated), "Cold" (deserted), or "Excluded" (immune cells stuck at the border).
Workflow
We offer an end-to-end pipeline designed to take you from raw tissue to actionable biological insights.

Deliverables
- Cellular spatial localization (tumor core/invasive margin/tertiary lymphoid structures TLS)
- Proximity quantification (distance and contact frequency between T cells and PD-L1⁺ cells)
- Spatial pattern recognition (immune cell clustering, exclusion gradients)
- Inferred cell communication (using ligand-receptor databases, such as CellPhoneDB spatial)
Key Applications
- Biomarker Discovery: Identify spatial signatures that predict response to Immune Checkpoint Inhibitors (ICIs).
- Drug Mechanism of Action (MoA): Visualize how a novel therapeutic changes the spatial distribution of immune cells post-treatment.
- Tertiary Lymphoid Structures (TLS) Mapping: Quantify the formation and maturity of immune "hubs" within the tumor.
Why Choose Our Service?
- Unrivaled Resolution: We move beyond "per-slide" averages to "per-cell" precision.
- Expert Interpretation: Our reports are written by PhD-level immunologists who translate raw spatial data into biological narratives.
- Platform Agnostic: Whether you have raw slides or digital images from a different provider, our pipeline can adapt.
- Scalability: From a single pilot slide to large clinical trial cohorts of hundreds of samples.
FAQs
How many markers can I analyze at once?
Depending on the platform (mIHC vs. PhenoCycler), we typically analyze between 6 and 40+ markers. For most spatial interaction studies, a 12-marker panel provides a robust view of the TME.
Can you analyze "Hot" vs "Cold" tumor regions specifically?
Yes. We use "Region of Interest" (ROI) selection to compare the invasive margin, the tumor core, and the surrounding stroma separately.
Learn about other Q&A.
Sample Requirements
Please consult with us to obtain detailed technical support prior to sample preparation, ensuring the smooth progress of the project.


